Kiderlen D, Worek F, Klimmek R, Eyer P (2000)
The phosphoryl oxime-destroying activity of human plasma
Archives of Toxicology 74: 27

Thiermann H, Mast U, Klimmek R, Eyer P, Hibler A, Pfab R, Felgenhauer N, Zilker T (1997)
Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients
Hum Exp Toxicol 16: 473

Worek F, Backer M, Thiermann H, Szinicz L, Mast U, Klimmek R, Eyer P (1997)
Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning
Hum Exp Toxicol 16: 466

Thiermann H, Radtke M, Spohrer U, Klimmek R, Eyer P (1996)
Pharmacokinetics of atropine in dogs after i.m. injection with newly developed dry/wet combination autoinjectors containing HI 6 or HLo 7
Archives of Toxicology 70: 293

Worek F, Klimmek R, Szinicz L (1995)
Effects of atropine and soman on the pharmacokinetics of the oxime HLo 7 dimethanesulfonate in anesthetized guinea-pigs
Drug & Chemical Toxicology 18: 137

Spohrer U, Thiermann H, Klimmek R, Eyer P (1994)
Pharmacokinetics of the oximes HI 6 and HLo 7 in dogs after i.m. injection with newly developed dry/wet autoinjectors
Archives of Toxicology 68: 480

Eyer P, Hagedorn I, Klimmek R, Lippstreu P, Loffler M, Oldiges H, Spohrer U, Steidl I, Szinicz L, Worek F (1992)
HLo 7 dimethanesulfonate, a potent bispyridinium-dioxime against anticholinesterases
Archives of Toxicology 66: 603

Klimmek R, Eyer P (1986)
Pharmacokinetics and pharmacodynamics of the oxime HI6 in dogs
Archives of Toxicology 59: 272

Klimmek R, Eyer P (1985)
Pharmacokinetics and toxicity of the oxime HGG 12 in dogs
Archives of Toxicology 57: 237